Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa
- PMID: 29287029
- PMCID: PMC5844830
- DOI: 10.1097/QAI.0000000000001616
Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa
Abstract
Background: Under Option B+ guidelines for prevention of mother-to-child transmission of HIV, pregnant and breastfeeding women initiate antiretroviral therapy for lifelong use. The objectives of this study were: (1) to synthesize data on retention in care over time in option B+ programs in Africa, and (2) to identify factors associated with retention in care.
Methods: PubMed, EMBASE, and African Index Medicus were systematically searched from January 2012 to June 2017. Pooled estimates of the proportion of women retained were generated and factors associated with retention were analyzed thematically.
Results: Thirty-five articles were included in the final review; 22 reported retention rates (n = 60,890) and 25 reported factors associated with retention. Pooled estimates of retention were 72.9% (95% confidence interval: 66.4% to 78.9%) at 6 months for studies reporting <12 months of follow-up and 76.4% (95% confidence interval: 69.0% to 83.1%) at 12 months for studies reporting ≥12 months of follow-up. Data on undocumented clinic transfers were largely absent. Risk factors for poor retention included younger age, initiating antiretroviral therapy on the same day as diagnosis, initiating during pregnancy versus breastfeeding, and initiating late in the pregnancy. Retention was compromised by stigma, fear of disclosure, and lack of social support.
Conclusions: Retention rates in prevention of mother-to-child transmission under option B+ were below those of the general adult population, necessitating interventions targeting the complex circumstances of women initiating care under option B+. Improved and standardized procedures to track and report retention are needed to accurately represent care engagement and capture undocumented transfers within the health system.
Figures
Similar articles
-
Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.BMC Public Health. 2018 Jun 27;18(1):805. doi: 10.1186/s12889-018-5651-y. BMC Public Health. 2018. PMID: 29945601 Free PMC article.
-
Cost and cost-effectiveness of transitioning to universal initiation of lifelong antiretroviral therapy for all HIV-positive pregnant and breastfeeding women in Swaziland.Trop Med Int Health. 2018 Sep;23(9):950-959. doi: 10.1111/tmi.13121. Epub 2018 Jul 26. Trop Med Int Health. 2018. PMID: 29956426
-
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.Lancet HIV. 2016 Apr;3(4):e175-82. doi: 10.1016/S2352-3018(16)00008-4. Epub 2016 Mar 9. Lancet HIV. 2016. PMID: 27036993 Free PMC article.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Adherence to HIV care after pregnancy among women in sub-Saharan Africa: falling off the cliff of the treatment cascade.Curr HIV/AIDS Rep. 2015 Mar;12(1):1-5. doi: 10.1007/s11904-014-0252-6. Curr HIV/AIDS Rep. 2015. PMID: 25620530 Free PMC article. Review.
Cited by
-
Outcomes After Loss to Follow-Up for Pregnant and Postpartum Women Living With HIV and Their Children in Kenya: A Prospective Cohort Study.J Acquir Immune Defic Syndr. 2024 Nov 1;97(3):242-252. doi: 10.1097/QAI.0000000000003487. Epub 2024 Oct 7. J Acquir Immune Defic Syndr. 2024. PMID: 39436797 Free PMC article.
-
Clinic transfers and engagement in HIV care during the perinatal period across a network of healthcare centers in Lilongwe, Malawi.BMC Pregnancy Childbirth. 2024 Oct 4;24(1):648. doi: 10.1186/s12884-024-06865-6. BMC Pregnancy Childbirth. 2024. PMID: 39367352 Free PMC article.
-
Acceptability and feasibility of using a blended quality improvement strategy among health workers to monitor women engagement in Option B+ program in Lilongwe Malawi.BMC Health Serv Res. 2024 Jul 25;24(1):842. doi: 10.1186/s12913-024-11342-z. BMC Health Serv Res. 2024. PMID: 39061055 Free PMC article.
-
Attrition from care and its predictors among women exposed to dolutegravir- and efavirenz-based first-line antiretroviral therapy in Ethiopia: a before-and-after study.Front Public Health. 2024 Jul 2;12:1385441. doi: 10.3389/fpubh.2024.1385441. eCollection 2024. Front Public Health. 2024. PMID: 39015389 Free PMC article.
-
Partner-Based HIV Treatment for Seroconcordant Couples Attending Antenatal and Postnatal Care in Rural Mozambique: A Cluster Randomized Controlled Trial.J Acquir Immune Defic Syndr. 2024 Jul 1;96(3):259-269. doi: 10.1097/QAI.0000000000003440. J Acquir Immune Defic Syndr. 2024. PMID: 38905476 Clinical Trial.
References
-
- UNAIDS. Prevention Gap Report. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2016.
-
- UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2014.
-
- Prendergast AJ, Essajee S, Penazzato M. HIV and the Millennium Development Goals. Arch Dis Child. 2015;100(Suppl 1):S48–52. - PubMed
-
- Helleringer S. Understanding the Adolescent Gap in HIV Testing Among Clients of Antenatal Care Services in West and Central African Countries. AIDS Behav. 2017;21(9):2760–2773. - PubMed
-
- WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach (Second edition) Geneva, Switzerland: World Health Organization; 2016. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

